Want to track RGC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Regencell Bioscience Holdings Ltd. (RGC) Statistics
Valuation metrics
Market Cap 3.38B
Enterprise value 3.41B
Trailing P/E (ttm) -485.21
Forward P/E -
PEG ratio 5.01
Price/Sales (ttm) -
Price/Book (mrq) 2,794.06
Enterprise Value/Revenue -
Enterprise Value/EBITDA -485.31
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 656K
Average volume (90 days) 380.4K
Price summary
52-Week low 4.51
52-Week high 69
Beta -
50-Day moving average 5.82
200-Day moving average 25
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 38:1
Last split Date 16 Jun 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -2.34%
Return on equity -2.32%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.01
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) 0.32
Current ratio (mrq) 1.42%
Book value per share (mrq) 0
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
